Abstract:Introduction Thrombotic events are present at higher rates among COVID-19 patients. Prophylactic use of parenteral anticoagulants during hospitalisation is recommended to reduce the risk of complications. In this context, the Tunisian Anticoagulation Survey in COVID-19 patient General Practice experience (TASC-GP) was conducted. Objective The evaluation of the incidence of venous thromboembolic events (VTE) and bleedings in COVID-19 patients treated in ambulatory. Method The TASC-GP is an observational, multicenter study included 3,383 patients from July to October 2021. The following up of patients was done 35 days after inclusion date with investigation of VTE and bleeding events. The four main enrolment criteria were: 1) age ≥ 18 years; 2) confirmed COVID-19 infection; 3) treated as an outpatient; 4) initiation of Rivaroxaban 10mg/d. Patients were excluded if any of the following criteria applied: 1) the use of anticoagulant or thrombolytic drugs other than Rivaroxaban on admission or within days of admission; 2) the use of any dosage other than that specified in the study protocol. Results The mean age of the population was 51.6±15.5 years with a sex ratio of 0.67, 30.7% of the population had hypertension, 23.4% were diabetic and 34.9% were obese. At least one cardiovascular comorbidity was observed in 40% of cases and 9.5% had chronic respiratory disease. The mean IMPROVE and IMPROVE DDimer scores were 0.65±0.9 and 1.4±1.4, respectively. The mean Improve bleeding score was 1.4 ± 1.5. A VTE was reported during follow-up in 39 patients (1.15%). Diabetes and chronic respiratory disease were independent factors for the occurrence of VTE with an odd ratio of 2.2 [95% CI 1.1–4.2] (P =0.017) and 3.2 [95% CI 1.5–6.4] (P =0.002) respectively. IMPROVE and IMPROVE DDimer scores were comparable in patients with and without VTE. There was no statistically significant increase in the rate of major bleeding (0.001%). The IMPROVE Bleeding score was comparable in the bleeding and non-bleeding groups at follow-up. There were no predictive factors for bleeding. Conclusion Our study is in agreement with the literature concerning a decrease in the rate of thrombembolic complications when using prophylactic anticoagulation versus placebo. Other VTE estimation scores including chronic respiratory disease and diabetes can be proposed. The use of Rivaroxaban in this population was not associated with increased bleeding.

Thrombose veineuse cérébrale : particularités d’une population tunisienne

Cerebral Venous Thrombosis: A Tunisian Monocenter Study on 160 Patients

A descriptive monocentric study in Algeria of adults with cerebral venous thrombosis

Particularités évolutives de l’accident vasculaire cérébral ischémique de l’artère choroïdienne antérieure : à propos d’une série tunisienne

Le thrombus libre flottant de la carotide interne : le challenge thérapeutique à travers une série de cas

Epidemiology, Clinical Features, and Outcome in a Cohort of Adolescents With Cerebral Venous Thrombosis

Cerebral venous thrombosis in elderly patients

Ischemic Stroke in Young Tunisian Adults

Hypertension intracrânienne idiopathique et facteurs favorisants : à propos de 20 cas

Causes Rares D'Hémorragie Intracérébrale

Post-traumatic cerebral venous sinus thrombosis in an intensive care unit: A case series of ten patients

Traitement Endovasculaire Des Anévrysmes Intracrâniens: Expérience De L'Unité De Nri Au Chu De Rabat

Moyamoya Angiopathy: An Underdiagnosed Cause of Ischemic Stroke in a Tunisian Pediatric Cohort

Challenges in Cerebral Venous Thrombosis Management—Case Reports and Short Literature Review

[Thrombolysis alert in ischemic stroke: experience of the international private clinic Al Badie in Fez (cross-sectional study of 60 cases)]

Clinico-epidemiological profile & outcome of patients presenting with cerebral venous thrombosis to emergency department

Assessment of eligibility for thrombolysis in acute ischaemic stroke patients in Morocco

Les épilepsies structurelles au service de neurologie du CHU Souss Massa au Maroc

Epidemiological and histopathological characteristics of thyroid carcinoma in a Tunisian health care center

Evaluation of the occurrence of venous thromboembolic events in COVID-19 outpatients

Knowledge and Perceptions of Cerebral Venous Thrombosis Among the Adult Population: A Nationwide Cross-Sectional Study in Saudi Arabia